Phosphodiesterase type 5 (PDE5) in the adipocyte: a novel player in fat metabolism?
Authors:
- Andrea ArmaniAAAndrea Armani
- Vincenzo MarzollaVMVincenzo Marzolla
- Giuseppe M.C. RosanoGRGiuseppe M.C. Rosano
- Andrea FabbriAFAndrea Fabbri
- Massimiliano CaprioMassimiliano Caprio
- 1 October 2011
- journal article
- review article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 22 (10) , 404-411
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Adipokines as novel biomarkers and regulators of the metabolic syndromeAnnals of the New York Academy of Sciences, 2010
- cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP ActionPharmacological Reviews, 2010
- Rho‐kinase/ROCK: A key regulator of the cytoskeleton and cell polarityCytoskeleton, 2010
- Effects of FoxO4 overexpression on cholesterol biosynthesis, triacylglycerol accumulation, and glucose uptakeJournal of Lipid Research, 2010
- PKG inhibits TCF signaling in colon cancer cells by blocking β-catenin expression and activating FOXO4Oncogene, 2010
- Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 PathwayPLOS ONE, 2009
- Insulin Stimulates Interleukin-6 Expression and Release in LS14 Human Adipocytes through Multiple Signaling PathwaysEndocrinology, 2008
- Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetesNature Reviews Molecular Cell Biology, 2008
- cAMP/PKA Regulates Osteogenesis, Adipogenesis and Ratio of RANKL/OPG mRNA Expression in Mesenchymal Stem Cells by Suppressing LeptinPLOS ONE, 2008
- Phosphodiesterase‐5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide‐mediated lipolysisBritish Journal of Pharmacology, 2007